Rigel's Mission
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.
Latest Presentation
Upcoming Event
European Hematology Association (EHA) 2025 Congress
Sign Up For Email Alerts
Receive updates straight into your inbox
Investor Contact Information
Company
Rigel Pharmaceuticals, Inc.
611 Gateway Blvd
Suite 900
South San Francisco, CA 94080
Investor Relations
Rigel Pharmaceuticals, Inc.
ir@rigel.com
Transfer Agent
EQ Shareowner Services
T: 800-401-1957